liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
NRF-mediated autophagy and UPR: Exploring new avenues to overcome cancer chemo-resistance
Shiraz Univ Med Sci, Iran.
Shiraz Univ Med Sci, Iran.
Tabriz Univ Med Sci, Iran.
Univ Manitoba, Canada.
Show others and affiliations
2025 (English)In: European Journal of Pharmacology, ISSN 0014-2999, E-ISSN 1879-0712, Vol. 988, article id 177210Article in journal (Refereed) Published
Abstract [en]

The development of chemo-resistance remains a significant hurdle in effective cancer therapy. NRF1 and NRF2, key regulators of redox homeostasis, play crucial roles in the cellular response to oxidative stress, with implications for both tumor growth and resistance to chemotherapy. This study delves into the dualistic role of NRF2, exploring its protective functions in normal cells and its paradoxical support of tumor survival and drug resistance in cancerous cells. We investigate the interplay between the PERK/NRF signaling pathway, ER stress, autophagy, and the unfolded protein response, offering a mechanistic perspective on how these processes contribute to chemoresistance. Our findings suggest that targeting NRF signaling pathways may offer new avenues for overcoming resistance to chemotherapeutic agents, highlighting the importance of a nuanced approach to redox regulation in cancer treatment. This research provides a molecular basis for the development of NRFtargeted therapies, potentially enhancing the efficacy of existing cancer treatments and offering hope for more effective management of resistant tumors.

Place, publisher, year, edition, pages
ELSEVIER , 2025. Vol. 988, article id 177210
Keywords [en]
NF-E2-related factor 2; Drug resistance; Reactive oxygen species; Autophagy; Unfolded protein response
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-211285DOI: 10.1016/j.ejphar.2024.177210ISI: 001403465900001PubMedID: 39706466Scopus ID: 2-s2.0-85212845788OAI: oai:DiVA.org:liu-211285DiVA, id: diva2:1934166
Available from: 2025-02-03 Created: 2025-02-03 Last updated: 2025-05-14

Open Access in DiVA

fulltext(5315 kB)162 downloads
File information
File name FULLTEXT01.pdfFile size 5315 kBChecksum SHA-512
c7eaf08a80c081a46063d9f4ccd88053f19c45865cccff60799f9ac467f96765fa635bd8955996090c91a72ec4243745c517563b5798c13c7fba657f5f275deb
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Wiechec, Emilia
By organisation
The Division of Cell and NeurobiologyFaculty of Medicine and Health SciencesDepartment of Otorhinolaryngology
In the same journal
European Journal of Pharmacology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 162 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 142 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf